Tcipatent Report 2016 Weeks 21-24
Share Embed Flag
Download ePaper

Tcipatent Report 2016 Weeks 21-24

Reports comprise records taken from the Online Database. Report Types:- 4-Weekly Reports published every 4 weeks showing the latest records added to the database – text-searchable PDFs, published since 1 January 2014. Back issues available. Bespoke Reports from the Database using selected criteria, e.g. by Drug, Patentee etc. (contact us for prices) Sample report contents: Axitinib, Bepridil, Canagliflozin, Carfilzomib, Caspofungin, Ceftolozane, Ceftolozane, Ceftolozane, Ceftolozane, Cytarabine, Daclatasvir, Docetaxel, Esomeprazole, Gadobutrol, Gemcitabine, Glycopyrronium bromide, Lansoprazole, Ledipasvir, Lurasidone, Metyrapone, Olmutinib, Ospemifene, Ospemifene, Pantoprazole, Rabeprazole, Regorafenib, Sapropterin, Sitagliptin, Sofosbuvir Reports comprise records taken from the Online Database. Report Types:-

4-Weekly Reports published every 4 weeks showing the latest records added to the database – text-searchable PDFs, published since 1 January 2014. Back issues available.
Bespoke Reports from the Database using selected criteria, e.g. by Drug, Patentee etc. (contact us for prices)

Sample report contents:

Axitinib, Bepridil, Canagliflozin, Carfilzomib, Caspofungin, Ceftolozane, Ceftolozane, Ceftolozane, Ceftolozane, Cytarabine, Daclatasvir, Docetaxel, Esomeprazole, Gadobutrol, Gemcitabine, Glycopyrronium bromide, Lansoprazole, Ledipasvir, Lurasidone, Metyrapone, Olmutinib, Ospemifene, Ospemifene, Pantoprazole, Rabeprazole, Regorafenib, Sapropterin, Sitagliptin, Sofosbuvir

tcipatent
30.07.2016 Views

New process patents for named, marketed, pharmaceutical drugs published Weeks 21 - 24/2016 (23 May - 19 June 2016) Drug Name: Vildagliptin Patent Specification Number: WO 2016/078109 Publication Date: 2016-05-26 First Filing Priority Details: 20141119CN10663657 Patentee: Suzhou Jonathan New Material Technology Co., Ltd. Patent Description: Vildagliptin appears to be obtained via the prepared intermediate (2S)-N-chloroacetyl-2-cyanopyrrolidine. Anagliptin also appears to be prepared. Significant Step: Claimed Comment: Not Clear Claimed Intermediate: Basic Patent Status: Application Stage Page 29

New process patents for named, marketed, pharmaceutical drugs published Weeks 21 - 24/2016 (23 May - 19 June 2016) Drug Name: Vortioxetine Patent Specification Number: EP 3023417 Publication Date: 2016-05-25 First Filing Priority Details: 20141121ITMI142018 Patentee: Dipharma Francis S.r.l Patent Description: Vortioxetine is obtained via claimed intermediate IV. Other intermediates are claimed. Significant Step: Claimed Comment: Claimed Claimed Intermediate: Basic Patent Status: Application Stage Page 30

New process patents for named, marketed, pharmaceutical drugs<br />

published <strong>Weeks</strong> <strong>21</strong> - <strong>24</strong>/<strong>2016</strong> (23 May - 19 June <strong>2016</strong>)<br />

Drug Name: Vortioxetine<br />

Patent Specification<br />

Number: EP 3023417<br />

Publication Date:<br />

<strong>2016</strong>-05-25<br />

First Filing<br />

Priority Details: 201411<strong>21</strong>ITMI142018<br />

Patentee: Dipharma Francis S.r.l<br />

Patent Description: Vortioxetine is obtained via claimed intermediate IV. Other intermediates are claimed.<br />

Significant Step:<br />

Claimed Comment: Claimed<br />

Claimed<br />

Intermediate:<br />

Basic Patent Status: Application Stage<br />

Page 30

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!